Study of the Intracorporeal Versus Extracorporeal Anastomosis in Right Hemicolectomy: HEMI-D-TREND-study (HEMI-D-TREND)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03918369|
Recruitment Status : Recruiting
First Posted : April 17, 2019
Last Update Posted : April 17, 2019
INTRODUCTION: Colorectal cancer is the second most frequent cancer in the Western world . Roughly a third of colorectal tumors are located in the right colon , and right hemicolectomy surgery is the treatment of choice in non-disseminated right colon cancer and other benign pathologies. Despite the introduction of laparoscopy and multimodal fast-track perioperative management programs in recent years, postoperative complication rates remain high. The most serious complication is anastomotic leak (AL), which is associated with increased mortality, longer hospital stay, and reduced quality of life due to the presence of ostomies. For a long time, the importance of ileo-colic AL was underestimated. However, the ANACO study1, conducted in 52 hospitals in our environment, reported a rate of AL of 8.4% with a range of 0 to 35%. This wide range is due to the differences in the surgical procedures and anastomoses used (the surgical approach may be open or laparoscopic, and the anastomosis may be manual or mechanical, with all its variations).
The results of intracorporeal laparoscopic anastomosis in the literature vary widely and, are discordant, although those reported so far estimate a DA less than 2%. But the latest publications report low rates of morbidity and of surgical space infection (SSI)5. The main problem with this technique is that it requires a learning curve somewhat greater than the others and its results depend on the skill of the surgeon and his casuistry. For all these reasons, it is necessary to carry out comparative studies that favor the use of this technique as gold standard.
The multicentre, controlled and randomized controlled studies have the disadvantage that randomization in centers not used with one of the techniques does include a learning curve bias. Besides the fact that in a center there is a belief that one of the techniques is superior to the other, it is not ethical to randomize the techniques. This situation has encouraged us to perform a non-randomized TREND-study design (Transparent Reporting of Evaluations with Non-randomized Designs-TREND).
To assess if laparoscopic right hemicolectomy, with anastomosis, obtains better results than laparoscopic with extracorporeal anastomosis and open surgery in terms of global morbidity, surgical space infection, anastomotic leak, re-interventions and hospital stay, in the first 30 postoperative days.
To analyze the rate of anastomotic leak (AL) and organ-cavitary infections in each hospital.
- Compare the results obtained with those published in the literature.
- Try to identify the risk factors associated with AL.
- Analyze the comorbidities associated with the type of incision made for the extraction of the surgical piece, in intra and extracorporeal anastomosis
|Condition or disease||Intervention/treatment||Phase|
|Colon Cancer||Procedure: Laparoscopic right hemicolectomy with intracorporeal anastomosis. Procedure: Laparoscopic right hemicolectomy with extracorporeal anastomosis.||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||456 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||A multicenter prospective, non-randomized, controlled study of the intracorporeal mechanical side-to-side isoperistaltic anastomosis versus extracorporeal anastomosis in laparoscopic right hemicolectomy. TREND-study|
|Masking:||None (Open Label)|
|Official Title:||A Multicenter Controlled Study of the Intracorporeal Mechanical Side-to-side Isoperistaltic Anastomosis Versus Extracorporeal Anastomosis in Laparoscopic Right Hemicolectomy: HEMI-D-TREND-study|
|Actual Study Start Date :||February 1, 2019|
|Estimated Primary Completion Date :||December 31, 2020|
|Estimated Study Completion Date :||February 1, 2021|
Experimental: Laparoscopic Intracorporeal anastomosis
Laparoscopic right hemicolectomy with intracorporeal mechanical side-to-side isoperistaltic anastomosis.
Procedure: Laparoscopic right hemicolectomy with intracorporeal anastomosis.
Intracorporeal anastomosis group The laparoscopic right hemicolectomy with intracorporeal mechanical side-to-side isoperistaltic anastomosis. In this procedure, intracorporeal division of the mesoileum and transverse colon is performed, as shown in the animation. The ileum and transverse colon are divided with the Endopath® Echelon Flex ™ 60 stapler. The specimen is inserted in a plastic bag. Side-to-side isoperistaltic mechanical anastomosis is performed using the same endostapler. A running suture is performed of the mechanical suture orifice, with another reinforcing suture with Monocryl ™ (poliglecaprone 25) or with STRATAFIX ™ Spiral Knotless barbed suture. The specimen is extracted through a Pfannestiel minilaparotomy (3.5-4 cm) Wound Protector
Active Comparator: Laparoscopic extracorporeal anastomosis
Laparoscopic right hemicolectomy with extracorporeal anastomosis.
Procedure: Laparoscopic right hemicolectomy with extracorporeal anastomosis.
Laparoscopic right hemicolectomy with extracorporeal anastomosis with the technical features of each center
- Anastomotic leak (AL) [ Time Frame: 30 days ]AL was defined in accordance with Peel et al.
- Global morbidity [ Time Frame: 30 days ]Dindo-Clavien Classification
- Surgical site infection [ Time Frame: 30 days ]SSI in accordance with the Center for Disease Control (CDC) National Nosocomial Infection Monitoring System
- Re-interventions [ Time Frame: 30 days ]Re-interventions due to surgical complications
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03918369
|Contact: Xavier Serra-Aracil, MD,PhD||34-93-723-1010 ext firstname.lastname@example.org|
|Hospital Universitario Parc Tauli de Sabadell||Recruiting|
|Sabadell, Barcelona, Spain, 08208|
|Contact: Xavier Serra-Aracil, MD 34937231010 ext 21490 email@example.com|
|Principal Investigator: Xavier Serra-Aracil, MD|
|Principal Investigator:||Xavier Serra-Aracil, MD, PhD||Corporacio Parc Tauli. Parc Tauli University Hospital|